Drug-eluting stents: Immediate and long-te1rm results

Hellenic Journal of Cardiology

Volumn 46, Issue 5, 2005, Pages 330-335

  Korovesis, Socrates ^a   Karvouni, Evangelia ^a   Giazitzoglou, Eleftherios ^a   Katritsis, Demosthenes ^a,b  

^a Cardiology Department   (Greece)

^b Athens Euroclinic   (Greece)

Author keywords

Paclitaxel; Restenosis; Sirolimus; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; PACLITAXEL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; SUSTAINED RELEASE PREPARATION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 29144486509     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Morice MC, Serruys PW, Sousa JE, et al: RAVEL Study Group: Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Grube E, Silber S, Hauptmann KE, et al: TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107: 38-42.
3. Moses JW, Leon MB, Popma JJ, et al: SIRIUS Investigators: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
4. Schofer J, Schluter M, Gershlick AH, et al: E-SIRIUS Investigators: Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.
5. Colombo A, Drzewiecki J, Banning A, et al: TAXUS II Study Group: Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794.
6. Stone GW, Ellis SG, Cox DA, et al: TAXUS-IV Investigators: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
7. Park SJ, Shim WH, Ho DS, et al: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-1545.
8. Schampaert E, Cohen EA, Schluter M, et al; C-SIRIUS Investigators: The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115.
9. Gershlick A, De Scheerder I, Chevalier B, et al: Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 2004; 109: 487-493.
10. Degertekin M, Regar E, Tanabe K, et al: Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 2003; 41: 184-189.
11. Tanabe K, Serruys PW, Grube E, et al: TAXUS III Trial: Instent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-564.
12. Lemos PA, van Mieghem CA, Arampatzis CA, et al: Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation 2004; 109: 2500-2502.
13. Colombo A, Moses JW, Morice MC, et al: Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
14. Lemos PA, Serruys PW, van Domburg RT, et al: Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109: 190-195.
15. Goy JJ, Urban P, Seydoux C, De Benedetti E, Stauffer JC: Use of sirolimus-eluting coronary stents in routine clinical practice. Catheter Cardiovasc Interv 2004; 62: 26-29.
16. Lemos PA, Saia F, Ligthart JM, et al: Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108: 257-260.
17. Colombo A, Orlic D, Stankovic G, et al: Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178-2180.
18. Mehran R, Dangas G, Abizaid AS, et al: Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
19. Serruys PW, de Jaegere P, Kiemeneij F, et al: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495.
20. Sousa JE, Costa MA, Abizaid AC, et al: Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-2011.
21. Serruys PW, Degertekin M, Tanabe K, et al: RAVEL Study Group: Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002; 106: 798-803.
22. Serruys PW, Degertekin M, Tanabe K, et al: TAXUS II Study Group: Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004; 109: 627-633.
23. Moussa I, Leon MB, Baim DS, et al: Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273-2278.
24. Dardas PS, Tsikaderis DD, Mezilis NE, Hatzimiltiadis S: Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents. Hell J Cardiol 2005; 46: 117-123.
25. Fujii K, Mintz GS, Kobayashi Y, et al: Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088.
26. Takebayashi H, Kobayashi Y, Dangas G, et al: Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv 2003; 60: 496-499.